Poornanand Palaparty
Hematology & Oncology · Cleveland, OHNPI 1982704375
Payments from drug & device makers
Across 134 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$334
- Novartis$310
- E.r. Squibb & Sons, L.L.C.$283
- Pharmacyclics LLC, An Abbvie Company$237
- Eisai Inc.$212
- Amgen$195
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,47993%
- Education$1887%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 11 | $334 |
| Novartis | 17 | $310 |
| E.r. Squibb & Sons, L.L.C. | 18 | $283 |
| Pharmacyclics LLC, An Abbvie Company | 13 | $237 |
| Eisai Inc. | 9 | $212 |
| Amgen | 9 | $195 |
| Bayer | 3 | $145 |
| Lilly USA, LLC | 5 | $100 |
| Genentech USA, Inc. | 6 | $84 |
| AstraZeneca | 5 | $82 |
| Sanofi | 3 | $68 |
| Pfizer | 4 | $66 |
| Boehringer Ingelheim | 4 | $49 |
| Merck | 3 | $48 |
| Rigel Pharmaceuticals, Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 3 | $47 |
| Taiho Oncology, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Array Biopharma Inc | 2 | $34 |
| EUSA Pharma (US) LLC | 1 | $31 |
| Gilead | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $23 |
| Epizyme, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Mylan Institutional Inc. | 1 | $15 |
| Seagen Inc. | 1 | $14 |
| Dova Pharmaceuticals | 1 | $13 |
| ADC Therapeutics America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$104
How this compares
$2,667 in reported general payments places this provider in the 35th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Cleveland
- Afshin DowlatiCleveland$25.1M
- Brian HillCleveland$11.6M
- Christopher HoimesCleveland$7.5M
- Balazs HalmosCleveland$7M
- Dale ShepardCleveland$5.1M
- Paolo CaimiCleveland$4.2M
- Allison WinterCleveland$4.2M
- Nathan PennellCleveland$3.8M
- Ankit ManglaCleveland$3.3M
- David BajorCleveland$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.